Study of the pharmacokinetic profile of the medicinal product Gidazepam®, tablets, 50 mg in a bioequivalence study

Study of the pharmacokinetic profile of the medicinal product Gidazepam®, tablets, 50 mg in a bioequivalence study

Aim. The primary aim of this study was to evaluate the pharmacokinetic parameters and confirm the bioequivalence of drugs containing gidazepam, namely Gidazepam® (Valenta Pharm, Russia) and Gidazepam VIC (VIVA Pharm, Republic of Kazakhstan), after a single administration of 1 tablet (50 mg) to health...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Baskakov, A. V. Grigorev, A. A. Globenko, A. G. Shmelev, E. A. Kolmykova, A. V. Yastrebova, A. A. Sidorova, A. V. Kapashin, O. V. Kovchan, A. I. Bashkatova, M. A. Pasko
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2023-11-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
gidazepam
pharmacokinetics
bioequivalence
benzodiazepines
Online Access:https://www.pharmacokinetica.ru/jour/article/view/386
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.pharmacokinetica.ru/jour/article/view/386

Similar Items